XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 91 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,329,000 | -39.8% | 1,358,825 | 0.0% | 0.06% | -29.3% |
| Q2 2021 | $5,530,000 | -28.4% | 1,358,825 | -20.6% | 0.08% | -24.8% |
| Q1 2021 | $7,722,000 | -34.5% | 1,712,304 | -28.6% | 0.11% | -23.8% |
| Q4 2020 | $11,795,000 | -17.0% | 2,397,441 | 0.0% | 0.14% | -45.2% |
| Q3 2020 | $14,217,000 | +122.9% | 2,397,441 | 0.0% | 0.26% | +121.2% |
| Q2 2020 | $6,377,000 | +10.6% | 2,397,441 | -18.9% | 0.12% | -27.2% |
| Q1 2020 | $5,767,000 | -72.7% | 2,957,441 | -1.4% | 0.16% | -68.0% |
| Q4 2019 | $21,155,000 | -28.3% | 3,000,641 | 0.0% | 0.51% | -48.7% |
| Q3 2019 | $29,496,000 | -14.1% | 3,000,641 | 0.0% | 0.99% | +1.6% |
| Q2 2019 | $34,327,000 | +13.9% | 3,000,641 | 0.0% | 0.97% | +10.2% |
| Q1 2019 | $30,126,000 | -26.5% | 3,000,641 | +24.4% | 0.88% | -46.6% |
| Q4 2018 | $41,015,000 | -3.3% | 2,412,641 | +0.0% | 1.65% | +26.4% |
| Q3 2018 | $42,414,000 | -7.4% | 2,412,640 | -0.0% | 1.30% | -16.1% |
| Q2 2018 | $45,792,000 | – | 2,412,642 | – | 1.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |